The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

NXG Insider Trading (NexgenRx)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$22,510.00
Insider Selling (Last 12 Months): C$0.00

NexgenRx Insider Trading History Chart

This chart shows the insider buying and selling history at NexgenRx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NexgenRx Share Price & Price History

Current Price: C$0.33
Price Change: Price Decrease of -0.02 (-5.71%)
As of 05/16/2022 03:15 PM ET

This chart shows the closing price history over time for NXG up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.

We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.

NexgenRx Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/12/2022Kelly Tyler EhlerSenior OfficerBuy8,500C$0.33C$2,805.00261,500
9/22/2021Paul Everett CrossettInsiderBuy14,000C$0.36C$5,040.002,348,638
8/30/2021Paul Everett CrossettInsiderBuy3,000C$0.36C$1,065.002,304,638
7/22/2021Paul Everett CrossettInsiderBuy25,000C$0.34C$8,500.002,301,638
7/14/2021Paul Everett CrossettInsiderBuy15,000C$0.34C$5,100.002,276,638
11/12/2020Paul Everett CrossettInsiderBuy23,500C$0.15C$3,525.002,186,638
9/11/2020Paul Everett CrossettInsiderBuy23,500C$0.17C$3,995.002,150,138
8/28/2020Paul Everett CrossettInsiderBuy18,000C$0.17C$3,060.002,126,638
6/5/2020Paul Everett CrossettInsiderBuy55,000C$0.18C$9,625.002,108,638
11/11/2019Paul Everett CrossettInsiderBuy16,000C$0.22C$3,520.001,876,638
11/8/2019Paul Everett CrossettInsiderBuy1,000C$0.22C$220.001,860,638
7/23/2019Paul Everett CrossettInsiderBuy500C$0.24C$120.001,729,138
7/19/2019Paul Everett CrossettInsiderBuy20,000C$0.24C$4,800.001,728,638
See Full Table
This Stock Under $2 Could Go to $20 (And STILL Be a SCREAMING BUY)
Analysts predict earnings will soar more than 320% this year...Possibly as much as 500%!

Discover the last opportunity that could still rocket skyward in THIS market.

Click Here to Discover Details on the Shocking Less Than $2 Stock.

SEC Filings (Institutional Ownership Changes) for NexgenRx (CVE:NXG)

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans in Canada. It offers prescription drug claims; dental claims; and claims for extended health benefits, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company also provides individual and aggregate stop loss products; medical emergency and travel assistance insurance services; administrative services, including the collection and payment of premiums for life and LTD coverage, as well as a suite of reporting tools; Web claims submission services; direct deposit services; and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.
Read More on NexgenRx

Today's Range

Now: C$0.33
Low: C$0.33
High: C$0.36

50 Day Range

MA: C$0.33
Low: C$0.31
High: C$0.35

52 Week Range

Now: C$0.33
Low: C$0.30
High: C$0.46


44,500 shs

Average Volume

47,971 shs

Market Capitalization

C$23.21 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of NexgenRx?

NexgenRx's top insider shareholders include:
  1. Paul Everett Crossett (Insider)
  2. Kelly Tyler Ehler (Senior Officer)
Learn More about top insider investors at NexgenRx.
Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward.
Get the Details Now.